image
Esperion Therapeutics, Inc. ESPR
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
Watchlist
$ 1.22
3.57 %
$ 242 M
Market Cap
-1.36
P/E
Price Target Average
883.61%
Revenue Forecast Estimate
33.35%
EBIT Estimate
--95.32%
Net Income Estimate
87.99%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Esperion Therapeutics, Inc.
image
Wall Street analysts predict an average 1-year price target for ESPR of $12 , with forecasts ranging from a low of $8 to a high of $20 .
ESPR Lowest Price Target Wall Street Target
8 USD 555.74%
ESPR Average Price Target Wall Street Target
12 USD 883.61%
ESPR Highest Price Target Wall Street Target
20 USD 1539.34%
Price
Max Price Target
Min Price Target
Average Price Target
2020181816161414121210108866442200Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
REVENUE FORECAST

Revenue Forecast Chart ESPR

image
$1.2b$1.2b$1.0b$1.0b$800.0m$800.0m$600.0m$600.0m$400.0m$400.0m$200.0m$200.0m$0.0$0.02019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart ESPR

image
$100.0m$100.0m$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)($400.0m)($400.0m)($500.0m)($500.0m)($600.0m)($600.0m)($700.0m)($700.0m)($800.0m)($800.0m)2019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart ESPR

image
$600.0m$600.0m$500.0m$500.0m$400.0m$400.0m$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)($400.0m)($400.0m)2019201920202020202120212022202220232023202420242025202520262026202720272028202820292029